Literature DB >> 32851375

Sacroiliitis in Systemic Lupus Erythematosus Revisited.

Neslihan Yilmaz1, Ayten Yazici2, Banu Özulu TÜrkmen3, Işık Karalok4, Şule Yavuz1.   

Abstract

OBJECTIVES: This study aims to investigate the prevalence of inflammatory back pain (IBP) and sacroiliitis in a systemic lupus erythematosus (SLE) population as well as the association between IBP and the frequency of human leukocyte antigen B27 (HLA-B27). PATIENTS AND METHODS: The study included 281 SLE patients (16 males, 265 females; mean age 39.9±11.9 years; range, 20 to 69 years) and 100 healthy controls (HCs) (2 males, 98 females; mean age 41.2±10.1 years; range, 19 to 64 years). Participants were administered a five-item Assessment of SpondyloArthritis international Society-IBP questionnaire. Patients and controls with IBP underwent detailed clinical and laboratory examinations to detect sacroiliitis. Radiographic evaluations were performed by a blinded rheumatologist and radiologist. Interobserver reliability was assessed with Cohen's kappa test.
RESULTS: According to the questionnaire, IBP was present in 46 SLE patients (46/281; 16.3%) whereas none of the HC had IBP (p<0.001). In radiological assessment, 22 SLE patients (7.8%) had sacroiliitis detected by conventional X-ray and/or magnetic resonance imaging. Only one SLE patient with sacroiliitis had HLA-B27.
CONCLUSION: Our study showed that IBP is increased in SLE patients and IBP in SLE is not associated with HLA-B27.
Copyright © 2020, Turkish League Against Rheumatism.

Entities:  

Keywords:  Inflammatory back pain; lupus; sacroiliitis

Year:  2020        PMID: 32851375      PMCID: PMC7406165          DOI: 10.46497/ArchRheumatol.2020.7514

Source DB:  PubMed          Journal:  Arch Rheumatol        ISSN: 2148-5046            Impact factor:   1.472


  21 in total

1.  Enrichment of circulating interleukin-17-secreting interleukin-23 receptor-positive γ/δ T cells in patients with active ankylosing spondylitis.

Authors:  Tony J Kenna; Stuart I Davidson; Ran Duan; Linda A Bradbury; Janelle McFarlane; Malcolm Smith; Helen Weedon; Shayna Street; Ranjeny Thomas; Gethin P Thomas; Matthew A Brown
Journal:  Arthritis Rheum       Date:  2012-05

2.  Detection of multiple autoantibodies in patients with ankylosing spondylitis using nucleic acid programmable protein arrays.

Authors:  Cynthia Wright; Sahar Sibani; David Trudgian; Roman Fischer; Benedikt Kessler; Joshua LaBaer; Paul Bowness
Journal:  Mol Cell Proteomics       Date:  2012-02       Impact factor: 5.911

3.  Articular manifestations of systemic lupus erythematosus.

Authors:  R Labowitz; H R Schumacher
Journal:  Ann Intern Med       Date:  1971-06       Impact factor: 25.391

Review 4.  Interleukin-17 in systemic lupus erythematosus: A comprehensive review.

Authors:  Duo Li; Bin Guo; Haijing Wu; Lina Tan; Christopher Chang; Qianjin Lu
Journal:  Autoimmunity       Date:  2015-04-20       Impact factor: 2.815

Review 5.  A systematic review of the global prevalence of low back pain.

Authors:  Damian Hoy; Christopher Bain; Gail Williams; Lyn March; Peter Brooks; Fiona Blyth; Anthony Woolf; Theo Vos; Rachelle Buchbinder
Journal:  Arthritis Rheum       Date:  2012-01-09

6.  Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria.

Authors:  Martin Rudwaleit; Anke Metter; Joachim Listing; Joachim Sieper; Jürgen Braun
Journal:  Arthritis Rheum       Date:  2006-02

7.  Tendinous and ligamentous derangements in systemic lupus erythematosus.

Authors:  Gabriela Sierra-Jimenez; Adriana Sanchez-Ortiz; Francisco Javier Aceves-Avila; Guillermo Hernandez-Rios; Sergio Durán-Barragán; Cesar Ramos-Remus
Journal:  J Rheumatol       Date:  2008-09-01       Impact factor: 4.666

8.  Sacroiliitis in systemic lupus erythematosus.

Authors:  M Kohli; R M Bennett
Journal:  J Rheumatol       Date:  1994-01       Impact factor: 4.666

9.  Accelerated pathological and clinical nephritis in systemic lupus erythematosus-prone New Zealand Mixed 2328 mice doubly deficient in TNF receptor 1 and TNF receptor 2 via a Th17-associated pathway.

Authors:  Noam Jacob; Haitao Yang; Luminita Pricop; Yi Liu; Xiaoni Gao; Song Guo Zheng; Juhua Wang; Hua-Xin Gao; Chaim Putterman; Michael N Koss; William Stohl; Chaim O Jacob
Journal:  J Immunol       Date:  2009-02-15       Impact factor: 5.422

10.  Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus.

Authors:  Agnès Doreau; Alexandre Belot; Jérémy Bastid; Benjamin Riche; Marie-Claude Trescol-Biemont; Bruno Ranchin; Nicole Fabien; Pierre Cochat; Claire Pouteil-Noble; Pierre Trolliet; Isabelle Durieu; Jacques Tebib; Berhouz Kassai; Stéphane Ansieau; Alain Puisieux; Jean-François Eliaou; Nathalie Bonnefoy-Bérard
Journal:  Nat Immunol       Date:  2009-05-31       Impact factor: 25.606

View more
  1 in total

Review 1.  A Narrative Literature Review Comparing the Key Features of Musculoskeletal Involvement in Rheumatoid Arthritis and Systemic Lupus Erythematosus.

Authors:  Thomas Dörner; Edward M Vital; Sarah Ohrndorf; Rieke Alten; Natalia Bello; Ewa Haladyj; Gerd Burmester
Journal:  Rheumatol Ther       Date:  2022-03-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.